Review paper
Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective
Volume: 22, Issue: 23, Pages: 12870 - 12870
Published: Nov 28, 2021
Abstract
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disease caused by deficient activity of acid sphingomyelinase (ASM) enzyme, leading to the accumulation of varying degrees of sphingomyelin. Lipid storage leads to foam cell infiltration in tissues, and clinical features including hepatosplenomegaly, pulmonary insufficiency and in some cases central nervous system involvement. ASM enzyme replacement therapy is currently in clinical...
Paper Details
Title
Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective
Published Date
Nov 28, 2021
Volume
22
Issue
23
Pages
12870 - 12870